Latest News On FDA

Latest California Healthline Stories

Qué le depara a la salud pública si se confirma Robert F. Kennedy Jr. como secretario de Salud

Científicos de las agencias federales de salud esperan la segunda administración de Donald Trump con incertidumbre y temor, preguntándose cómo el presidente electo conciliará filosofías radicalmente diferentes entre los líderes de su equipo.

What’s at Stake: A Pivotal Election for Six Big Health Issues

Health care has ebbed and surged as an election issue throughout the presidential campaign. Here are the ways some of the most consequential changes in health policies could hinge on whether Vice President Kamala Harris or former President Donald Trump wins.

KFF Health News' 'What the Health?': Less Than Two Weeks To Go

With Election Day rapidly approaching, abortion is gaining traction as a voting issue, according to public opinion polls. Meanwhile, states with abortion bans are reviving the lawsuit — dismissed by the Supreme Court on a technicality this year — that could roll back the availability of the abortion pill mifepristone. Sarah Karlin-Smith of the Pink Sheet, Rachel Cohrs Zhang of Stat, and Victoria Knight of Axios join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Tricia Neuman, senior vice president of KFF and executive director of its Program on Medicare Policy, about Medicare open enrollment and the changes to the federal program for 2025.

With TV Drug Ads, What You See Is Not Necessarily What You Get

The pharmaceutical industry has invented a new art form: finding ways to make their wares seem like joyous must-have treatments, while often minimizing lackluster efficacy and risks.